Home
GPCR
GPCR News

Latest Structure Therapeutics Inc. (GPCR) News on August 22, 2025

Jefferies Reiterates a Buy Rating on Structure Therapeutics (GPCR) With a $79 PT

Insider Monkey

2 months ago

Jefferies Reiterates a Buy Rating on Structure Therapeutics (GPCR) With a $79 PT

Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-2671

GlobeNewswire

2 months ago

Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-2671

Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences

GlobeNewswire

3 months ago

Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences

Structure Therapeutics Reports First Quarter 2025 Financial Results and Recent Highlights

GlobeNewswire

3 months ago

Structure Therapeutics Reports First Quarter 2025 Financial Results and Recent Highlights

MT Newswires

4 months ago

Citigroup Initiates Coverage on Structure Therapeutics With Buy Rating, $60 Price Target

Is Structure Therapeutics Inc. (NASDAQ:GPCR) the Most Promising Small-Cap Stock According to Analysts?

Insider Monkey

4 months ago

Is Structure Therapeutics Inc. (NASDAQ:GPCR) the Most Promising Small-Cap Stock According to Analysts?

Eli Lilly jumps as results from weight-loss pill study rival competitor’s

TipRanks

4 months ago

Eli Lilly jumps as results from weight-loss pill study rival competitor’s

JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics

TipRanks

4 months ago

JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics

Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill

TipRanks

4 months ago

Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill

NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback

Zacks

4 months ago

NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback

AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.

Investor's Business Daily

6 months ago

AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.

MT Newswires

6 months ago

William Blair Initiates Structure Therapeutics at Outperform

Structure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights

GlobeNewswire

6 months ago

Structure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights

Why Structure Therapeutics Stock Was Stumbling This Week

Motley Fool

6 months ago

Why Structure Therapeutics Stock Was Stumbling This Week

Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences

GlobeNewswire

7 months ago

Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences

We're Not Very Worried About Structure Therapeutics' (NASDAQ:GPCR) Cash Burn Rate

Simply Wall St.

7 months ago

We're Not Very Worried About Structure Therapeutics' (NASDAQ:GPCR) Cash Burn Rate

Merck Licenses a Weight-Loss Pill. It’s Bad News for Obesity Biotechs.

Barrons.com

8 months ago

Merck Licenses a Weight-Loss Pill. It’s Bad News for Obesity Biotechs.

Structure Therapeutics Announces Selection of Lead Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity

GlobeNewswire

8 months ago

Structure Therapeutics Announces Selection of Lead Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity

Is Structure Therapeutics Inc. (GPCR) the Best Weight Loss Stock to Buy Now According to Hedge Funds?

Insider Monkey

8 months ago

Is Structure Therapeutics Inc. (GPCR) the Best Weight Loss Stock to Buy Now According to Hedge Funds?

Jefferies Predicts Up to ~1000% Surge for These 2 ‘Strong Buy’ Stocks

TipRanks

8 months ago

Jefferies Predicts Up to ~1000% Surge for These 2 ‘Strong Buy’ Stocks

MT Newswires

9 months ago

HC Wainwright Initiates Structure Therapeutics at Buy

Why Is Structure Therapeutics Inc. (GPCR) Among the Best Up and Coming Stocks to Buy According to Analysts?

Insider Monkey

9 months ago

Why Is Structure Therapeutics Inc. (GPCR) Among the Best Up and Coming Stocks to Buy According to Analysts?

Structure Therapeutics Inc. (GPCR): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts

Insider Monkey

9 months ago

Structure Therapeutics Inc. (GPCR): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts

Structure Therapeutics to Participate in the Jefferies London Healthcare Conference

GlobeNewswire

9 months ago

Structure Therapeutics to Participate in the Jefferies London Healthcare Conference

Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights

GlobeNewswire

9 months ago

Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights

Structure Therapeutics Announces First Patients Dosed in Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist, GSBR-1290, for Obesity

GlobeNewswire

9 months ago

Structure Therapeutics Announces First Patients Dosed in Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist, GSBR-1290, for Obesity

Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2024

GlobeNewswire

10 months ago

Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2024

GPCR drugmaker Septerna amasses $288M in IPO

BioPharma Dive

10 months ago

GPCR drugmaker Septerna amasses $288M in IPO

Structure Therapeutics (GPCR): Innovating Oral Therapies for Obesity and Diabetes

Insider Monkey

10 months ago

Structure Therapeutics (GPCR): Innovating Oral Therapies for Obesity and Diabetes

Does Structure Therapeutics Inc. Sponsored ADR (GPCR) Have the Potential to Rally 115.8% as Wall Street Analysts Expect?

Zacks

10 months ago

Does Structure Therapeutics Inc. Sponsored ADR (GPCR) Have the Potential to Rally 115.8% as Wall Street Analysts Expect?

As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer

Investor's Business Daily

a year ago

As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer

Is Structure Therapeutics Inc. (GPCR) the Best Young Stock To Buy Now?

Insider Monkey

a year ago

Is Structure Therapeutics Inc. (GPCR) the Best Young Stock To Buy Now?

MT Newswires

a year ago

Structure Therapeutics Shares Rise After Morgan Stanley Begins Coverage at Overweight

MT Newswires

a year ago

Morgan Stanley Initiates Structure Therapeutics at Overweight

High-Flying Novo Nordisk Dips On Disappointing Data for Weight-Loss Pill

The Wall Street Journal

a year ago

High-Flying Novo Nordisk Dips On Disappointing Data for Weight-Loss Pill

MT Newswires

a year ago

Structure Therapeutics Names Chief Medical Officer, Chief Development Officer

Structure Therapeutics Strengthens Executive Team with Promotion of Blai Coll, M.D., Ph.D. to Chief Medical Officer and Appointment of Ashley Hall, J.D. as Chief Development Officer

GlobeNewswire

a year ago

Structure Therapeutics Strengthens Executive Team with Promotion of Blai Coll, M.D., Ph.D. to Chief Medical Officer and Appointment of Ashley Hall, J.D. as Chief Development Officer

NVO Oral Obesity Pill Tops Wegovy; LLY, VKTX, GPCR Stocks Rise

Zacks

a year ago

NVO Oral Obesity Pill Tops Wegovy; LLY, VKTX, GPCR Stocks Rise

Structure Therapeutics Inc. (GPCR): Among the Best Mid-Cap Healthcare Stocks To Buy Now

Insider Monkey

a year ago

Structure Therapeutics Inc. (GPCR): Among the Best Mid-Cap Healthcare Stocks To Buy Now

Structure Therapeutics Appoints Angus C. Russell to Board of Directors

GlobeNewswire

a year ago

Structure Therapeutics Appoints Angus C. Russell to Board of Directors

Structure Therapeutics Announces Participation in Upcoming Investor Conferences

GlobeNewswire

a year ago

Structure Therapeutics Announces Participation in Upcoming Investor Conferences

Companies Like Structure Therapeutics (NASDAQ:GPCR) Are In A Position To Invest In Growth

Simply Wall St.

a year ago

Companies Like Structure Therapeutics (NASDAQ:GPCR) Are In A Position To Invest In Growth

Don’t Forget This Startup’s Weight-Loss Pill, Analyst Says

Barrons.com

a year ago

Don’t Forget This Startup’s Weight-Loss Pill, Analyst Says

Don’t Forget This Start-Up’s Weight-Loss Pill, Analyst Says

Barrons.com

a year ago

Don’t Forget This Start-Up’s Weight-Loss Pill, Analyst Says

Why Are Hedge Funds Bullish on Structure Therapeutics Inc. (GPCR) Now?

Insider Monkey

a year ago

Why Are Hedge Funds Bullish on Structure Therapeutics Inc. (GPCR) Now?

Structure Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights

GlobeNewswire

a year ago

Structure Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights

What's in Store for Structure Therapeutics (GPCR) in Q2 Earnings?

Zacks

a year ago

What's in Store for Structure Therapeutics (GPCR) in Q2 Earnings?

Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?

Benzinga

a year ago

Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?

Could Structure Therapeutics Become the Next Novo Nordisk?

Motley Fool

a year ago

Could Structure Therapeutics Become the Next Novo Nordisk?

Structure Therapeutics (GPCR) Rallying on Obesity Drug Data

Zacks

a year ago

Structure Therapeutics (GPCR) Rallying on Obesity Drug Data

Structure Therapeutics Stock Could Rocket 87% Higher, According to 1 Wall Street Analyst. Is It Time to Buy?

Motley Fool

a year ago

Structure Therapeutics Stock Could Rocket 87% Higher, According to 1 Wall Street Analyst. Is It Time to Buy?

Structure Therapeutics' Stock Is Soaring on the Promise of Its Wegovy Competitor, but Is It a Buy?

Motley Fool

a year ago

Structure Therapeutics' Stock Is Soaring on the Promise of Its Wegovy Competitor, but Is It a Buy?

MT Newswires

a year ago

Structure Therapeutics Closes $547.4 Million Offering

Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares

GlobeNewswire

a year ago

Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares

MT Newswires

a year ago

BMO Capital Adjusts Price Target on Structure Therapeutics to $100 From $83, Maintains Outperform Rating

Flash News: OKX Launches 'Trade and Earn' Campaign Featuring 2,500,000 Ultiverse Tokens

GlobeNewswire

a year ago

Flash News: OKX Launches 'Trade and Earn' Campaign Featuring 2,500,000 Ultiverse Tokens

Sustainable Construction Practices and Modular Techniques Drive Dry Construction Market to $127.69 Billion by 2029

GlobeNewswire

a year ago

Sustainable Construction Practices and Modular Techniques Drive Dry Construction Market to $127.69 Billion by 2029

Advantech Releases FWA-3051, The Latest 1U Rackmount Edge Networking Solution with Intel® Xeon® D-2700/2800 Series

PR Newswire

a year ago

Advantech Releases FWA-3051, The Latest 1U Rackmount Edge Networking Solution with Intel® Xeon® D-2700/2800 Series

Hydrogen Storage Market Set to Hit $6.8 Billion by 2031, registering a solid CAGR of 23% - Exclusive Report by Coherent Market Insights

GlobeNewswire

a year ago

Hydrogen Storage Market Set to Hit $6.8 Billion by 2031, registering a solid CAGR of 23% - Exclusive Report by Coherent Market Insights

Shake Shack (SHAK) Rose after Strong Q4 Results

Insider Monkey

a year ago

Shake Shack (SHAK) Rose after Strong Q4 Results

Flash News: OKX to List Ultiverse's Token on its Perpetual Futures Market, Expanding Trading Options

GlobeNewswire

a year ago

Flash News: OKX to List Ultiverse's Token on its Perpetual Futures Market, Expanding Trading Options

"Green Energy" Brings Charging Piles to Mountain Villages

PR Newswire

a year ago

"Green Energy" Brings Charging Piles to Mountain Villages

Global UV-Curable Adhesives Market Report 2024: Rising Demand in Electronics and Packaging Drives UV-Curable Adhesives Market to $605.4 Million by 2032

GlobeNewswire

a year ago

Global UV-Curable Adhesives Market Report 2024: Rising Demand in Electronics and Packaging Drives UV-Curable Adhesives Market to $605.4 Million by 2032

MT Newswires

a year ago

Structure Therapeutics Prices Upsized $476 Million Stock Offering

Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering

GlobeNewswire

a year ago

Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering

Heard on the Street Monday Recap: Catnip

The Wall Street Journal

a year ago

Heard on the Street Monday Recap: Catnip

MT Newswires

a year ago

Structure Therapeutics Plans Offering of American Depositary Shares

Structure Therapeutics Announces Proposed Public Offering of American Depositary Shares and Pre-Funded Warrants

GlobeNewswire

a year ago

Structure Therapeutics Announces Proposed Public Offering of American Depositary Shares and Pre-Funded Warrants

MT Newswires

a year ago

Top Midday Gainers

Structure Therapeutics Stock Skyrockets To Six-Month High On Compelling Weight-Loss Drug Results

Investor's Business Daily

a year ago

Structure Therapeutics Stock Skyrockets To Six-Month High On Compelling Weight-Loss Drug Results

MT Newswires

a year ago

Structure Therapeutics Reports Positive Topline Data From Obesity Trial; Shares Jump

Heard on the Street: Wall Street Is Cheering a New Obesity Pill Candidate. Here's Why.

The Wall Street Journal

a year ago

Heard on the Street: Wall Street Is Cheering a New Obesity Pill Candidate. Here's Why.

Structure Therapeutics Stock Soars on Obesity Pill Data

The Wall Street Journal

a year ago

Structure Therapeutics Stock Soars on Obesity Pill Data

Structure pill leads to competitive weight loss in obesity study

BioPharma Dive

a year ago

Structure pill leads to competitive weight loss in obesity study

Structure Therapeutics Reports Positive Topline Data from its Phase 2a Obesity Study and Capsule to Tablet PK Study for its Oral Non-Peptide Small Molecule GLP-1 Receptor Agonist GSBR-1290

GlobeNewswire

a year ago

Structure Therapeutics Reports Positive Topline Data from its Phase 2a Obesity Study and Capsule to Tablet PK Study for its Oral Non-Peptide Small Molecule GLP-1 Receptor Agonist GSBR-1290

J.P. Morgan Predicts up to 210% Gains for These 2 ‘Strong Buy’ Stocks

TipRanks

a year ago

J.P. Morgan Predicts up to 210% Gains for These 2 ‘Strong Buy’ Stocks

MT Newswires

a year ago

JPMorgan Starts Structure Therapeutics With Overweight Rating

Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights

GlobeNewswire

a year ago

Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights

We Think Structure Therapeutics (NASDAQ:GPCR) Can Afford To Drive Business Growth

Simply Wall St.

a year ago

We Think Structure Therapeutics (NASDAQ:GPCR) Can Afford To Drive Business Growth

Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference

GlobeNewswire

a year ago

Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference

Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights

GlobeNewswire

a year ago

Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights

3 Stocks to Buy for Consistent Sales Growth

Zacks

2 years ago

3 Stocks to Buy for Consistent Sales Growth

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30

CNW Group

2 years ago

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30

Business Wire

2 years ago

Form 8.3 - DX (Group) plc

Africa Smart Manufacturing Market Sees Upsurge: Comprehensive Analysis and Growth Forecasts Up to 2030

GlobeNewswire

2 years ago

Africa Smart Manufacturing Market Sees Upsurge: Comprehensive Analysis and Growth Forecasts Up to 2030

Copa Holdings (CPA) Stock Moves -0.07%: What You Should Know

Zacks

2 years ago

Copa Holdings (CPA) Stock Moves -0.07%: What You Should Know

Valley National Bancorp Full Year 2023 Earnings: EPS Misses Expectations

Simply Wall St.

2 years ago

Valley National Bancorp Full Year 2023 Earnings: EPS Misses Expectations

Capital One (COF) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks

2 years ago

Capital One (COF) Reports Q4 Earnings: What Key Metrics Have to Say

Booz Allen (BAH) Invests in Albedo For VLEO Satellite Imaging

Zacks

2 years ago

Booz Allen (BAH) Invests in Albedo For VLEO Satellite Imaging

AbbVie Stock Moves With Rising Relative Strength, Still Room To Grow

Investor's Business Daily

2 years ago

AbbVie Stock Moves With Rising Relative Strength, Still Room To Grow

Here's Why You Should Add Xenon (XENE) to Your Portfolio Now

Zacks

2 years ago

Here's Why You Should Add Xenon (XENE) to Your Portfolio Now

Here’s Why Structure Therapeutics (GPCR) Fell in Q4

Insider Monkey

2 years ago

Here’s Why Structure Therapeutics (GPCR) Fell in Q4

SITE Centers Announces Tax Allocations of 2023 Dividend Distributions

Business Wire

2 years ago

SITE Centers Announces Tax Allocations of 2023 Dividend Distributions

GOGL – Changes to the Board composition

GlobeNewswire

2 years ago

GOGL – Changes to the Board composition

Where Will Marathon Digital Stock Be in 10 Years?

Motley Fool

2 years ago

Where Will Marathon Digital Stock Be in 10 Years?

Here is Why Growth Investors Should Buy Silicon Motion (SIMO) Now

Zacks

2 years ago

Here is Why Growth Investors Should Buy Silicon Motion (SIMO) Now

With EPS Growth And More, RBC Bearings (NYSE:RBC) Makes An Interesting Case

Simply Wall St.

2 years ago

With EPS Growth And More, RBC Bearings (NYSE:RBC) Makes An Interesting Case

HashiCorp Inc CMO Marc Holmes Sells 13,916 Shares

GuruFocus.com

2 years ago

HashiCorp Inc CMO Marc Holmes Sells 13,916 Shares

Polestar announces Board and Management appointments

Business Wire

2 years ago

Polestar announces Board and Management appointments

Freshworks to Participate in 26th Annual Needham Growth Conference

GlobeNewswire

2 years ago

Freshworks to Participate in 26th Annual Needham Growth Conference

Share on Social Networks: